A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals

Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
12/2004
12/15/2004	EP1485075A2 Mhc-peptide complex binding ligands
12/15/2004	EP1421176A4 Nucleic acids and encoded polypeptides associated with bipolar disorder
12/15/2004	CN1179640C Method for cultivating Huliotis discus hannai Ino
12/15/2004	CN1179639C Technology for industrially culturing trichogamma with gelechiid ova
12/09/2004	WO2004106497A2 Imageable animal model of sars infection
12/09/2004	WO2004017728A3 Methods
12/09/2004	WO2003100070A3 The frog prince, a transposon vector for gene transfer in vertebrates
12/09/2004	WO2003057835A3 Pak5-related compositions and methods
12/09/2004	US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders
12/09/2004	US20040250303 Animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
12/09/2004	US20040250302 Transgenic flies expressing Abeta42-dutch
12/09/2004	US20040250301 Transgenic animals
12/09/2004	US20040250300 Expression of proteins in milk
12/09/2004	US20040250299 Compound screening method
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248829 Gene expression in embryonic pancreas cells, adipocytes; prevent metabolic disorders; antidiabetic agents; obesity; eating disorders; neurodegenerative disorders
12/09/2004	US20040248296 HIV therapeutic
12/09/2004	US20040248262 Nucleotide sequences coding lysosomal protein for use treatment of brain and muscular disorders
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248211 Hybridoma cell line comprising intracellular adhesion molecules for use in generating immunoglobulins to treatment autoimmune, skin and inflammatory disorders
12/09/2004	US20040248179 Cbg gene as a genetic marker of hypercortisolism and associated pathologies
12/09/2004	US20040248178 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
12/09/2004	US20040248149 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design
12/09/2004	US20040248133 Method for determining cell cycle position
12/09/2004	US20040247595 Related to the potassium channel subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity
12/09/2004	US20040247572 Hair follicle-reconstitution system and animal carrying the same
12/09/2004	US20040244341 Automatic system-based animal training device
12/09/2004	CA2527296A1 Imageable animal model of sars infection
12/09/2004	CA2525853A1 Method for cloning in the rat by nuclear transfer
12/09/2004	CA2525717A1 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
12/08/2004	EP1484415A2 Method of alleviating pest infestation in plants
12/08/2004	EP1484395A1 Transposon being functional in mammals
12/08/2004	EP1483588A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
12/08/2004	EP1483288A2 Hbm variants that modulate bone mass and lipid levels
12/08/2004	EP1482983A2 Non-myeloablative tolerogenic treatment with tyrphostins
12/08/2004	EP1386150A4 Insect ammunition vectors and methods of use to identify pesticide targets
12/08/2004	EP0782628B1 Improvement of an expression vector for production of recombinant proteins
12/08/2004	CN1552202A Method for breeding scallops by hybrid
12/08/2004	CN1179048C Modified MSP-1 nucleic acid sequences and method for increasing mRN-A level and protein expression in cell system
12/07/2004	US6828472 Animal models
12/07/2004	US6828471 Immune defective rodent for use in the classification, evaluation and treatment of cancer
12/07/2004	US6828433 DNA encoding mutated collagen X
12/07/2004	US6828430 For prognosis/treatment; poly(A) binding protein II (PAB II)
12/07/2004	US6828144 Method of observing vasculogenesis in vitro using cultured allantois
12/06/2004	CA2469992A1 Transgenic animal model for glyt1 function
12/02/2004	WO2004104200A1 Method of controlling cell proliferation by using novel function of myeloid leukemia factor mlf1 and utilization of the same
12/02/2004	WO2004104045A1 Therapeutical use of anti-cd70 antibody for treating or preventing aids
12/02/2004	WO2004103067A2 A transgenic animal model for cancer and stem cells
12/02/2004	WO2004067746A8 Ires
12/02/2004	WO2004049794A3 Single chain antibodies produced in a transgenic mouse
12/02/2004	WO2003095667A3 Autoimmune conditions and nadph oxidase defects
12/02/2004	WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof
12/02/2004	WO2003014298A3 Full-length prostate selective polynucleotides and polypeptides
12/02/2004	US20040244070 Expression of polypeptides in rod outer segment membranes
12/02/2004	US20040244067 Transgenic mammal which has increased lung mucus retention and whose genome comprises a promoter linked to a heterologous DNA encoding an epithelial sodium channel subunit; useful in treatment of bronchitis and asthma.
12/02/2004	US20040244064 Transgenic flies expressing Abeta42-Flemish
12/02/2004	US20040244063 Transgenic rodent comprising and expressing nucleotide sequences coding blood coagulation factors for use in treatment of cardiovascular disorders
12/02/2004	US20040242525 Method for promoting gonadal growth in an animal
12/02/2004	US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis
12/02/2004	US20040242487 Identifying a subject in need of inhibiting appetite or weight gain and administering an effective amount of an antagonist of melanocyte concentrating hormone (MCH) to subject, wherein antagonist binds an MCH receptor
12/02/2004	US20040242482 Methods for altering fate of a cell, tissue or organ type by simultaneously changing the activation state of the Notch pathway and one or more cell fate control gene pathways; use in cell replacement therapy to repopulate lost cell populations and help in regeneration of diseased and/or injured tissues
12/02/2004	US20040241822 Nutrient solution that enhances infection of silkworms by virus; bioreactors and heterologous gene expression
12/02/2004	US20040241808 Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations
12/02/2004	US20040241761 Using human estrogen receptor gene expression as diagnostic indicator of diabetes; antidiabetic agents
12/02/2004	US20040241723 Identifying polymorphic sequences which are associated with an obesity gene and enhanced milk and milk protein production
12/02/2004	US20040241694 Using expression patter of neurodegenerative marker to diagnose/prognose brain disorders
12/02/2004	US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines
12/02/2004	US20040241640 Internalisation of virus into cells
12/02/2004	CA2526650A1 A pair of probes for analyzing protein-protein interaction and a method for analyzing protein-protein interaction using the same
12/02/2004	CA2525181A1 Tnf-like secreted protein
12/01/2004	EP1482035A1 Process for producing physiologically active protein using genetically modified silkworm
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1481093A2 MODULATION OF TYPE II&bgr; PHOSPHOINOSITIDE PHOSPHATE KINASE
12/01/2004	EP1481063A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils
12/01/2004	EP1481007A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom
12/01/2004	EP1480670A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480515A2 Inbred embryonic stem-cell derived mice
12/01/2004	EP1480514A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1073745B1 Immunization against and treatment for infection by h. pylori
12/01/2004	EP0912611B9 Human monoclonal antibodies to the hepatitis b surface antigen
12/01/2004	CN1551726A Hair follicle-reconstitution system and animal carrying the same
11/2004
11/30/2004	US6825396 Methods for tissue specific synthesis of protein in eggs of transgenic hens
11/30/2004	US6825395 Transgenic non-human mammals expressing the human complement inhibitor (DAF/CD55)
11/30/2004	US6825394 For in vitro analysis of differentiated epithelial/neuronal cells; bioassays
11/30/2004	US6825332 Gene related to migraine in man
11/30/2004	US6825035 For drug screening; gene knockout; genetic engineering
11/25/2004	WO2004102195A1 Method for identifying tff2 regulating agents and agents identified using said method
11/25/2004	WO2004100773A2 Diagnostic and therapeutic treatments related to mitochondrial disorders
11/25/2004	WO2004067736A3 Custom-made meganuclease and use thereof
11/25/2004	WO2004063346A3 Lysozyme transgenic ungulates
11/25/2004	WO2004022722A3 Lentiviral vectors, related reagents, and methods of use thereof
11/25/2004	US20040237145 Control of gene expression
11/25/2004	US20040237129 Transgenic rodent model for use in identifying modulators for treatment of cell proliferative disorders; antitumor agents; immunotherapy
11/25/2004	US20040237128 Transgenic non-human animal having a disruption of at least one allele to the ceacam 1 gene and method of making same
11/25/2004	US20040237127 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
11/25/2004	US20040235764 Methods of inhibiting expression of a target gene in mammalian cells

1 ... 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 ... 341